Consensus Poolbeg Pharma PLC

Equities

POLB

GB00BKPG7Z60

Delayed London S.E. Other stock markets 10:00:28 04/06/2024 BST			5-day change	1st Jan Change
13.99 ^GBX	-1.85%		+5.02%	+52.60%

05-01	Poolbeg Pharma Secures Full Patent in US for Immunomodulator II	MT
05-01	Poolbeg Pharma celebrates full patent approval for Immunomodulator II	AN

Evolution of the average Target Price on Poolbeg Pharma PLC

Price target over the last 5 years

History of analyst recommendation changes

2f772a3532fc3471adc3.M_YD0HoDOnvYJBYUVGP-J6i6YPdNFDw4q5lSIlDffbE.arVCpANMXS7qQFV2MSiLHs_MA70aZ3lq2-MfGwnmMPB-wm-7SVZvQ5B0eQ~162d2949fec504dffc449781fcb10c69

Analyst Recommendations on Poolbeg Pharma PLC

Time Out revenue rises; Arbuthnot gets rates boost	30/03/23	AN
Proactive's Robin Davison publishes fresh research note on Poolbeg Pharma	09/03/23	AQ

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.1425 GBP

Average target price

0.21 GBP

Spread / Average Target

+47.37%

High Price Target

0.23 GBP

Spread / Highest target

+61.40%

Low Price Target

0.19 GBP

Spread / Lowest Target

+33.33%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar